AI assistant
Sending…
ERYTECH Pharma S.A. — Regulatory Filings 2016
Feb 8, 2016
1295_dva_2016-02-08_c0e8aea9-dc99-41c5-89d3-0a80962b0def.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
Information related to total number of voting rights and shares composing the share capital January 2016
Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France
Listing market: Euronext Paris from Euronext Market segment : segment B ISIN Code : FR0011471135 website : www.erytech.com
| Date | Total of shares composing | Total of brut(1) voting | Total of net(2) voting |
|---|---|---|---|
| the share capital | rights | rights | |
| 31 January 2016 | 7 924 611 | 9 706 437 | 9 703 937 |
(1) Gross voting rights number (or « theoretical » voting rights) is used as a calculus base for the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares
More from ERYTECH Pharma S.A.
Delisting Announcement
2025
Jun 18
Delisting Announcement
2025
Jun 18
Delisting Announcement
2025
Jun 12
Delisting Announcement
2025
Jun 12
Legal Proceedings Report
2025
Jun 5
Delisting Announcement
2025
Jun 5
Delisting Announcement
2025
May 22
Legal Proceedings Report
2025
May 22
Legal Proceedings Report
2025
May 5
Legal Proceedings Report
2025
May 5